Otodental syndrome
(Redirected from Otodental dysplasia)
Otodental syndrome is a rare genetic disorder characterized by abnormalities in the development of the teeth and ears. It is also known as otodental dysplasia. The condition is inherited in an autosomal dominant manner, meaning that only one copy of the altered gene is sufficient to cause the disorder.
Clinical Features[edit | edit source]
Individuals with otodental syndrome typically present with a combination of dental and auditory anomalies. The dental abnormalities include globodontia, which is characterized by unusually large, bulbous teeth, particularly affecting the canine and molar teeth. These teeth often have a distinctive globular shape and may be prone to dental caries and other dental issues.
Auditory anomalies in otodental syndrome can include sensorineural hearing loss, which is a type of hearing loss resulting from damage to the inner ear or the auditory nerve. The degree of hearing loss can vary among affected individuals.
Genetics[edit | edit source]
Otodental syndrome is caused by mutations in the FGF3 gene, which plays a crucial role in the development of the teeth and ears. The FGF3 gene provides instructions for making a protein that is involved in the signaling pathways that regulate the growth and development of various tissues and organs.
Diagnosis[edit | edit source]
The diagnosis of otodental syndrome is based on clinical evaluation, detailed patient history, and the identification of characteristic dental and auditory features. Genetic testing can confirm the diagnosis by identifying mutations in the FGF3 gene.
Management[edit | edit source]
Management of otodental syndrome involves a multidisciplinary approach, including regular dental care to address the dental anomalies and audiological assessments to monitor and manage hearing loss. Hearing aids or other assistive devices may be recommended for individuals with significant hearing impairment.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD